<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="28/04/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9724088" creator="Noriko Katsu">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>9724088</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term sem="Cell_natural" id="T1" lex="peripheral_T_lymphocyte">Peripheral T <term sem="Cell_natural" id="T2" lex="lymphocyte">lymphocytes</term></term> from <term sem="Multicellular_organism_natural" id="T3" lex="woman">women</term> with breast cancer exhibit abnormal protein expression of <term sem="Protein_family_or_group" id="T4" lex="several_signaling_molecule">several signaling molecules</term>.</sentence>
<event id="E1">
<type class="Gene_expression" />
<theme idref="T4" />
<clue><clueLoc>Peripheral T lymphocytes</clueLoc> from women with breast cancer exhibit abnormal protein <clueType>expression</clueType> <linkTheme>of</linkTheme> several signaling molecules.</clue>
</event>
<event id="E28">
<type class="Negative_regulation" />
<theme idref="E1" />
<clue>Peripheral T lymphocytes from women with breast cancer <clueType>exhibit abnormal</clueType> protein expression of several signaling molecules.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">We examined signaling molecules of <term sem="Cell_natural" id="T5" lex="peripheral_blood_T_lymphocyte">peripheral blood T lymphocytes</term> obtained from women with <term sem="Other" id="T6" lex="breast_cancer">breast cancer</term>.</sentence>
<sentence id="S3">In 6 of 14 <term sem="Multicellular_organism_natural" id="T7" lex="patient">patients</term>, <term sem="Cell_natural" id="T8" lex="T_lymphocyte">T lymphocytes</term> displayed an impaired ability to translocate <term sem="Protein_molecule" id="T9" lex="NFeB_p65">NFeB p65</term> (<term sem="Protein_molecule" id="T10" lex="Rel-A">Rel-A</term>) following activation by <term sem="Protein_molecule" id="A1">anti-CD3</term> and <term sem="Protein_molecule" id="T11" lex="IL-2">IL-2</term>.</sentence>
<event id="E2">
<type class="Physiological_process" />
<theme idref="T8" />
<cause idref="A1" />
<clue>In 6 of 14 patients, T lymphocytes displayed an impaired ability to translocate NFeB p65 (Rel-A) following <clueType>activation</clueType> <linkCause>by</linkCause> anti-CD3 and IL-2.</clue>
</event>
<event id="E3">
<type class="Physiological_process" />
<theme idref="T8" />
<cause idref="T11" />
<clue>In 6 of 14 patients, T lymphocytes displayed an impaired ability to translocate NFeB p65 (Rel-A) following <clueType>activation</clueType> <linkCause>by</linkCause> anti-CD3 and IL-2.</clue>
</event>
<event id="E31">
<type class="Negative_regulation" />
<theme idref="E4" />
<cause idref="E2" />
<clue>In 6 of 14 patients, <clueLoc>T lymphocytes</clueLoc> displayed an <clueType>impaired</clueType> ability to translocate NFeB p65 (Rel-A) <linkCause>following</linkCause> activation by anti-CD3 and IL-2.</clue>
</event>
<event id="E32">
<type class="Negative_regulation" />
<theme idref="E5" />
<cause idref="E3" />
<clue>In 6 of 14 patients, <clueLoc>T lymphocytes</clueLoc> displayed an <clueType>impaired</clueType> ability to translocate NFeB p65 (Rel-A) <linkCause>following</linkCause> activation by anti-CD3 and IL-2.</clue>
</event>
<event id="E4">
<type class="Localization" />
<theme idref="T10" />
<clue>In 6 of 14 patients, <clueLoc>T lymphocytes</clueLoc> displayed an impaired ability to <clueType>translocate</clueType> NFeB p65 (Rel-A) following activation by anti-CD3 and IL-2.</clue>
</event>
<event id="E5">
<type class="Positive_regulation" />
<theme idref="E4" />
<cause idref="E2" />
<clue>In 6 of 14 patients, T lymphocytes displayed an impaired ability to translocate NFeB p65 (Rel-A) <linkCause>following</linkCause> activation by anti-CD3 and IL-2.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E33">
<type class="Positive_regulation" />
<theme idref="E4" />
<cause idref="E3" />
<clue>In 6 of 14 patients, T lymphocytes displayed an impaired ability to translocate NFeB p65 (Rel-A) <linkCause>following</linkCause> activation by anti-CD3 and IL-2.</clue>
<comment>NO CLUETYPE</comment>
</event>
<sentence id="S4">This observation was made despite normal <term sem="Other" id="T12" lex="cytoplasmic_level">cytoplasmic levels</term> of the <term sem="Protein_molecule" id="T13" lex="Rel-A_protein">Rel-A protein</term>.</sentence>
<event id="E29">
<type class="Gene_expression" />
<theme idref="T13" />
<clue>This observation was made despite normal <clueLoc>cytoplasmic</clueLoc> <clueType>levels</clueType> <linkTheme>of</linkTheme> the Rel-A protein.</clue>
</event>
<sentence id="S5">We also detected abnormally low levels of the <term sem="Protein_family_or_group" id="T14" lex="signaling_molecule">signaling molecules</term> <term sem="Protein_molecule" id="T15" lex="T-cell_receptor_(TCR)-zeta">T-cell receptor (TCR)-zeta</term>, <term sem="Protein_molecule" id="T16" lex="ZAP-70">ZAP-70</term> and <term sem="Protein_molecule" id="T17" lex="p56lck">p56lck</term> in 4 of 14 <term sem="Other" id="T18" lex="breast_cancer">breast cancer</term> <term sem="Multicellular_organism_natural" id="T19" lex="patient">patients</term>, i.e., defects in <term sem="Protein_family_or_group" id="T20" lex="T-cell_signaling_molecule">T-cell <term sem="Protein_family_or_group" id="T21" lex="signaling_molecule">signaling molecules</term></term>.</sentence>
<event id="E6">
<type class="Negative_regulation" />
<theme idref="T15" />
<clue>We also <clueType>detected</clueType> abnormally <clueType>low levels</clueType> <linkTheme>of</linkTheme> <corefTheme>the signaling molecules</corefTheme> T-cell receptor (TCR)-zeta, ZAP-70 and p56lck in 4 of 14 breast cancer patients, i.e., defects in T-cell signaling molecules.</clue>
</event>
<event id="E7">
<type class="Negative_regulation" />
<theme idref="T16" />
<clue>We also <clueType>detected</clueType> abnormally <clueType>low levels</clueType> <linkTheme>of</linkTheme> <corefTheme>the signaling molecules</corefTheme> T-cell receptor (TCR)-zeta, ZAP-70 and p56lck in 4 of 14 breast cancer patients, i.e., defects in T-cell signaling molecules.</clue>
</event>
<event id="E8">
<type class="Negative_regulation" />
<theme idref="T17" />
<clue>We also <clueType>detected</clueType> abnormally <clueType>low levels</clueType> <linkTheme>of</linkTheme> <corefTheme>the signaling molecules</corefTheme> T-cell receptor (TCR)-zeta, ZAP-70 and p56lck in 4 of 14 breast cancer patients, i.e., defects in T-cell signaling molecules.</clue>
</event>
<event id="E30">
<type class="Negative_regulation" />
<theme idref="T20" />
<clue>We also detected abnormally low levels of the signaling molecules T-cell receptor (TCR)-zeta, ZAP-70 and p56lck in 4 of 14 breast cancer patients, i.e., <clueType>defects</clueType> <linkTheme>in</linkTheme> T-cell signaling molecules.</clue>
</event>
<sentence id="S6"><term sem="Cell_natural" id="T22" lex="T_lymphocyte">T lymphocytes</term> from 6 of the 14 <term sem="Multicellular_organism_natural" id="T23" lex="patient">patients</term> also exhibited an increased expression of the dual <term sem="Protein_family_or_group" id="T24" lex="specificity_phosphatase">specificity phosphatase</term>, <term sem="Protein_molecule" id="T25" lex="map_kinase_phosphatase-1">map kinase phosphatase-1</term> (<term sem="Protein_molecule" id="T26" lex="MKP-1">MKP-1</term>).</sentence>
<event id="E9">
<type class="Positive_regulation" />
<theme idref="E10" />
<clue><clueLoc>T lymphocytes</clueLoc> from 6 of the 14 patients also exhibited an <clueType>increased</clueType> expression of the dual specificity phosphatase, map kinase phosphatase-1 (MKP-1).</clue>
</event>
<event id="E10">
<type class="Gene_expression" />
<theme idref="T26" />
<clue>T lymphocytes from 6 of the 14 patients also exhibited an increased <clueType>expression</clueType> <linkTheme>of</linkTheme> the <corefTheme>dual specificity phosphatase</corefTheme>, map kinase phosphatase-1 (MKP-1).</clue>
</event>
<sentence id="S7"><term sem="Protein_molecule" id="T27" lex="MKP-1">MKP-1</term> inactivates <term sem="Protein_family_or_group" id="T28" lex="MAP_kinase">MAP kinase</term> and therefore may interfere with the activation of <term sem="DNA_domain_or_region" id="T29" lex="c-jun">c-jun</term> and <term sem="DNA_domain_or_region" id="T30" lex="c-fos">c-fos</term>.</sentence>
<event id="E11">
<type class="Negative_regulation" />
<theme idref="T28" />
<cause idref="T27" />
<clue>MKP-1 <clueType>inactivates</clueType> MAP kinase and therefore may interfere with the activation of c-jun and c-fos.</clue>
</event>
<event uncertainty="probable" id="E12">
<type class="Negative_regulation" />
<theme idref="E14" />
<cause idref="E11" />
<clue>MKP-1 inactivates MAP kinase and <corefCause>therefore</corefCause> may <clueType>interfere</clueType> <linkTheme>with</linkTheme> the activation of c-jun and c-fos.</clue>
</event>
<event uncertainty="probable" id="E13">
<type class="Negative_regulation" />
<theme idref="E15" />
<cause idref="E11" />
<clue>MKP-1 inactivates MAP kinase and <corefCause>therefore</corefCause> may <clueType>interfere</clueType> <linkTheme>with</linkTheme> the activation of c-jun and c-fos.</clue>
</event>
<event id="E14">
<type class="Positive_regulation" />
<theme idref="T29" />
<clue>MKP-1 inactivates MAP kinase and therefore may interfere with the <clueType>activation</clueType> <linkTheme>of</linkTheme> c-jun and c-fos.</clue>
</event>
<event id="E15">
<type class="Positive_regulation" />
<theme idref="T30" />
<clue>MKP-1 inactivates MAP kinase and therefore may interfere with the <clueType>activation</clueType> <linkTheme>of</linkTheme> c-jun and c-fos.</clue>
<comment>CAUTION: S8, &quot;I or more&quot;, correctly &quot;1 or more&quot;</comment>
</event>
<sentence id="S8">Abnormalities of I or more <term sem="Protein_family_or_group" id="T31" lex="signaling_molecule">signaling molecules</term> were found in 9 of 14 <term sem="Multicellular_organism_natural" id="T32" lex="patient">patients</term>; however, only 3 <term sem="Multicellular_organism_natural" id="T33" lex="patient">patients</term> had <term sem="Cell_natural" id="T34" lex="T_cell">T cells</term> that exhibited all 5 defects.</sentence>
<sentence id="S9">Our data have implications for the detection of potentially dysfunctional <term sem="Cell_natural" id="T35" lex="T_cell">T cells</term> in <term sem="Multicellular_organism_natural" id="T36" lex="patient">patients</term> with <term sem="Other" id="T37" lex="cancer">cancer</term>.</sentence>
<sentence id="S10">For example, the analysis of only 1 <term sem="Protein_family_or_group" id="T38" lex="signaling_molecule">signaling molecule</term> may allow <term sem="Multicellular_organism_natural" id="T39" lex="patient">patients</term> with significant defects in T-cell signaling to go unnoticed.</sentence>
<sentence id="S11">Finally, despite impaired <term sem="Other" id="T40" lex="Rel-A_translocation"><term sem="Protein_molecule" id="T41" lex="Rel-A">Rel-A</term> translocation</term>, <term sem="Cell_natural" id="T42" lex="T_cell">T cells</term> were capable of transcribing <term sem="DNA_domain_or_region" id="A3"><term sem="Protein_molecule" id="T43" lex="IL-2">IL-2</term></term>.</sentence>
<event id="E16">
<type class="Localization" />
<theme idref="T41" />
<clue>Finally, despite impaired Rel-A <clueType>translocation</clueType>, T cells were capable of transcribing IL-2.</clue>
</event>
<event id="E17">
<type class="Negative_regulation" />
<theme idref="E16" />
<clue>Finally, despite <clueType>impaired</clueType> Rel-A translocation, T cells were capable of transcribing IL-2.</clue>
</event>
<event id="E18">
<type class="Transcription" />
<theme idref="A3" />
<clue>Finally, despite impaired Rel-A translocation, <clueLoc>T cells</clueLoc> were capable of <clueType>transcribing</clueType> IL-2.</clue>
</event>
<event assertion="non-exist" id="E19">
<type class="Negative_regulation" />
<theme idref="E18" />
<cause idref="E17" />
<clue>Finally, <linkCause>despite</linkCause> impaired Rel-A translocation, T cells were capable of transcribing IL-2.</clue>
<comment>NO CLUETYPE</comment>
</event>
<sentence id="S12">Impairments in the translocation of <term sem="Protein_molecule" id="T44" lex="Rel-B">Rel-B</term> and <term sem="Protein_molecule" id="T45" lex="c-Rel">c-Rel</term> further suggest that the <term sem="Protein_family_or_group" id="T46" lex="NFKB_family_member">NFKB family members</term> <term sem="Protein_molecule" id="T47" lex="Rel-A">Rel-A</term>, <term sem="Protein_molecule" id="T48" lex="Rel-B">Rel-B</term> and <term sem="Protein_molecule" id="T49" lex="c-Rel">c-Rel</term> are not required for the transcription of <term sem="DNA_domain_or_region" id="A4"><term sem="Protein_molecule" id="T50" lex="IL-2">IL-2</term></term> in the <term sem="Cell_natural" id="T51" lex="peripheral_T_lymphocyte">peripheral <term sem="Cell_natural" id="T52" lex="T_lymphocyte">T lymphocytes</term></term> of <term sem="Multicellular_organism_natural" id="T53" lex="patient">patients</term> with <term sem="Other" id="T54" lex="breast_cancer">breast cancer</term>.</sentence>
<event id="E20">
<type class="Localization" />
<theme idref="T44" />
<clue>Impairments in the <clueType>translocation</clueType> <linkTheme>of</linkTheme> Rel-B and c-Rel further suggest that the NFKB family members Rel-A, Rel-B and c-Rel are not required for the transcription of IL-2 in the peripheral T lymphocytes of patients with breast cancer.</clue>
</event>
<event id="E21">
<type class="Localization" />
<theme idref="T45" />
<clue>Impairments in the <clueType>translocation</clueType> <linkTheme>of</linkTheme> Rel-B and c-Rel further suggest that the NFKB family members Rel-A, Rel-B and c-Rel are not required for the transcription of IL-2 in the peripheral T lymphocytes of patients with breast cancer.</clue>
</event>
<event id="E22">
<type class="Negative_regulation" />
<theme idref="E20" />
<clue><clueType>Impairments</clueType> <linkTheme>in</linkTheme> the translocation of Rel-B and c-Rel further suggest that the NFKB family members Rel-A, Rel-B and c-Rel are not required for the transcription of IL-2 in the peripheral T lymphocytes of patients with breast cancer.</clue>
</event>
<event id="E23">
<type class="Negative_regulation" />
<theme idref="E21" />
<clue><clueType>Impairments</clueType> <linkTheme>in</linkTheme> the translocation of Rel-B and c-Rel further suggest that the NFKB family members Rel-A, Rel-B and c-Rel are not required for the transcription of IL-2 in the peripheral T lymphocytes of patients with breast cancer.</clue>
</event>
<event assertion="non-exist" uncertainty="probable" id="E24">
<type class="Regulation" />
<theme idref="E27" />
<cause idref="T47" />
<clue>Impairments in the translocation of Rel-B and c-Rel further suggest that the <corefCause>NFKB family members</corefCause> Rel-A, Rel-B and c-Rel are not <clueType>required</clueType> <linkTheme>for</linkTheme> the transcription of IL-2 <clueLoc>in the peripheral T lymphocytes</clueLoc> of patients with breast cancer.</clue>
</event>
<event assertion="non-exist" uncertainty="probable" id="E25">
<type class="Regulation" />
<theme idref="E27" />
<cause idref="T47" />
<clue>Impairments in the translocation of Rel-B and c-Rel further suggest that the <corefCause>NFKB family members</corefCause> Rel-A, Rel-B and c-Rel are not <clueType>required</clueType> <linkTheme>for</linkTheme> the transcription of IL-2 <clueLoc>in the peripheral T lymphocytes</clueLoc> of patients with breast cancer.</clue>
</event>
<event assertion="non-exist" id="E26">
<type class="Regulation" />
<theme idref="E27" />
<cause idref="T47" />
<clue>Impairments in the translocation of Rel-B and c-Rel further suggest that the <corefCause>NFKB family members</corefCause> Rel-A, Rel-B and c-Rel are not <clueType>required</clueType> <linkTheme>for</linkTheme> the transcription of IL-2 <clueLoc>in the peripheral T lymphocytes</clueLoc> of patients with breast cancer.</clue>
</event>
<event id="E27">
<type class="Transcription" />
<theme idref="A4" />
<clue>Impairments in the translocation of Rel-B and c-Rel further suggest that the NFKB family members Rel-A, Rel-B and c-Rel are not required for the <clueType>transcription</clueType> <linkTheme>of</linkTheme> IL-2 in the peripheral T lymphocytes of patients with breast cancer.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
